Novus Biologicals products are now on bio-techne.com

Recombinant Human PD-L1/B7-H1 Fc Chimera Protein, CF

Images

 
Recombinant human B7-H1/Fc (Catalog # 156-B7) has a molecular weight (MW) of 135.0 kDa as analyzed by SEC-MALS, suggesting that this protein is a homodimer.  MW may differ from predicted MW due to post-translational ...read more
Recombinant Human PD-L1 / B7-H1 Fc Chimera (Catalog # 156-B7) inhibits anti-CD3 antibody-induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.075-0.75 µg/mL in the presence of Goat Anti-Human ...read more
Recombinant Human PD-L1/B7-H1 Fc protein (Catalog # 156-B7) was immobilized on a Biacore Sensor Chip CM5, and binding to Recombinant Human PD-1 His protein (8986-PD) was measured at a concentration range between 6.0 nM ...read more

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Bioactivity
Format
Carrier-Free

Order Details

View Available Formulations
Catalog# & Formulation Size Price
Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

Recombinant Human PD-L1/B7-H1 Fc Chimera Protein, CF Summary

Additional Information
Analyzed by SEC-MALS
Details of Functionality
Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.075-0.75 μg/mL.
Source
Mouse myeloma cell line, NS0-derived human PD-L1/B7-H1 protein
Human PD-L1
(Phe19-Thr239)
Accession # Q9NZQ7
DIEGRMD Human IgG1
(Pro100-Lys330)
N-terminus C-terminus
Accession #
N-terminal Sequence
Phe19
Structure / Form
Disulfide-linked homodimer
Protein/Peptide Type
Recombinant Proteins
Gene
CD274
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.01 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Bioactivity
Theoretical MW
52 kDa (monomer).
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
70-75 kDa, reducing conditions
Publications
Read Publications using
156-B7 in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS and NaCl.
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human PD-L1/B7-H1 Fc Chimera Protein, CF

  • Avelumab
  • B7-H
  • B7H1
  • B7-H1
  • B7H1PDCD1L1
  • CD274 antigenMGC142294
  • CD274 molecule
  • CD274
  • PDCD1L1
  • PDCD1LG1
  • PDCD1LG1MGC142296
  • PDL1
  • PD-L1
  • PD-L1B7 homolog 1
  • PDL1PDCD1 ligand 1
  • programmed cell death 1 ligand 1
  • Programmed death ligand 1

Background

PD-L1, also known as B7-H1, PDL1, is one of the ligands for PD-1 and plays a critical role in the regulation of T cell immunity (1-6). The PD-1:PD-L1 interaction initiates a negative signaling cascade in T cells leading to inhibition of T cell activation (2, 5, 7, 8). PD-L1 provides a molecular stop signal to the adaptive immune system helping to distinguish between self and foreign antigens. PD-L1 also plays a role in the development of immune tolerance by promoting T cell anergy (1, 5) and enhancing regulatory T cell development (8). In addition, PD-L1 favors the development of anti-inflammatory IL-10 and IL-22 producing dendritic cells (7, 9) and inhibits the development of Th17 cells (8). Many cancers exhibit upregulated PD-L1 protein expression, and several cancers with high levels of PD-L1 have been associated with increased tumor aggressiveness and poor prognosis. Using new therapeutics that block the PD-L1:PD-1 interaction has proven successful in the clinic for many cancer types and has sparked great interest in the field of cancer immunotherapy.

The PD-L1 protein is an approximately 65 kDa transmembrane glycoprotein belonging to the B7 family of immune regulatory molecules (10). Mature human PD-L1 protein consists of a 220 amino acid (aa) extracellular domain (ECD) with two immunoglobulin-like domains, a 21 aa transmembrane segment, and a 31 aa cytoplasmic domain (11). Within the ECD, human PD-L1 shares 73% and 74% aa sequence identity with mouse and rat B7-H1, respectively. Alternative splicing generates additional isoforms that either lack the first Ig-like domain or are truncated within the second Ig-like domain (12). PD-L1 is expressed on inflammatory-activated immune cells including macrophages, T cells, and B cells (10, 13, 14, 16) keratinocytes (9, 11), endothelial and intestinal epithelial cells (2, 9), as well as a variety of carcinomas and melanoma (12, 16).

  1. Tsushima, F. et al. (2007) Blood 110:180.
  2. Mazanet, M.M. and C.C.W. Hughes (2002) J. Immunol. 169:3581.
  3. Azuma, T. et al. (2008) Blood 111:3635.
  4. Butte, M.J. et al. (2008) Mol. Immunol. 45:3567.
  5. Park, J.-J. et al. (2010) Blood 116:1291.
  6. Ritprajak, P. et al. (2010) J. Immunol. 184:4918.
  7. Chen, L. et al. (2007) J. Immunol. 178:6634.
  8. Herold, M. et al. (2015) J. Immunol. 195:3584.
  9. Scandiuzzi, L. et al. (2014) Cell Rep. 6:625.
  10. Ceeraz, S. et al. (2013) Trends Immunol. 34:556.
  11. Dong, H. et al. (1999) Nat. Med. 5:1365.
  12. Frigola, X. et al. (2011) Clin. Cancer Res. 17:1915.
  13. Tamura, H. et al. (2001) Blood 97:1809.
  14. Kuang, D.-M. et al. (2014) J. Clin. Invest. 124:4657.
  15. Cao, Y. et al. (2010) Cancer Res. 71:1235.
  16. Dong, H. et al. (2002) Nat. Med. 8:793.

Customers Who Viewed This Item Also Viewed...

AF1086
Species: Hu
Applications: Block, CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, IHC, WB
MAB1224
Species: Hu
Applications: IHC, WB
7268-CT
Species: Hu
Applications: BA
MAB140
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, IHC, Neut
MAB7158
Species: Hu, Mu
Applications: IHC, WB
NB100-524
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
NBP2-79843
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
DY417
Species: Mu
Applications: ELISA
NBP1-49045
Species: Mu, Rt
Applications: Cell Depl, CyTOF-ready, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, InhibTFunc
NBP1-19371
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
202-IL
Species: Hu
Applications: BA
NBP2-25208
Species: Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P, KO, WB
NBP1-72042
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, PEP-ELISA, WB
MAB342
Species: Hu
Applications: AgAct, ICC, WB
NB100-39002
Species: Bv, Hu, Mu, Rt
Applications: Dual ISH-IHC, Flow, IB, ICC/IF, IHC, IHC-P, IP, Single-Cell Western, WB
AF165
Species: Hu
Applications: CyTOF-ready, Flow, WB
6507-IL/CF
Species: Hu
Applications: BA
AF169
Species: Hu
Applications: IHC, WB

Publications for PD-L1 (156-B7)(32)

We have publications tested in 4 confirmed species: Human, N/A, Yeast, Yeast - Saccharomyces cerevisiae.

We have publications tested in 9 applications: Binding Assay, Bioassay, CAR-T (Bioassay), ELISA (Standard), ELISA Capture, ELISA Standard, Flow Cytometry, Immunoassay Development, In vitro assay.


Filter By Application
Binding Assay
(1)
Bioassay
(19)
CAR-T (Bioassay)
(1)
ELISA (Standard)
(4)
ELISA Capture
(1)
ELISA Standard
(2)
Flow Cytometry
(2)
Immunoassay Development
(1)
In vitro assay
(1)
All Applications
Filter By Species
Human
(27)
N/A
(1)
Yeast
(1)
Yeast - Saccharomyces cerevisiae
(1)
All Species
Showing Publications 1 - 10 of 32. Show All 32 Publications.
Publications using 156-B7 Applications Species
Wu, B;Huang, X;Shi, X;Jiang, M;Liu, H;Zhao, L; LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer Molecular cancer 2024-09-02 [PMID: 39223601] (ELISA Standard, Human) ELISA Standard Human
Darwish, IA;Alahmad, W;Vinoth, R; Novel ultrasensitive automated kinetic exclusion assay for measurement of plasma levels of soluble PD-L1, the predictive and prognostic biomarker in cancer patients treated with immune checkpoint inhibitors Heliyon 2024-05-30 [PMID: 38803937] (Immunoassay Development, Human) Immunoassay Development Human
Jeong, H;Koh, J;Kim, S;Song, SG;Lee, SH;Jeon, Y;Lee, CH;Keam, B;Lee, SH;Chung, DH;Jeon, YK; Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer British journal of cancer 2024-05-10 [PMID: 38729997] (In vitro assay, N/A) In vitro assay N/A
Straube, J;Bukhari, S;Lerrer, S;Winchester, R;Henick, B;Dragovich, M;Mor, A; PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis bioRxiv : the preprint server for biology 2023-11-17 [PMID: 38014321] (Bioassay, Human) Bioassay Human
Manna, L;Rapuano Lembo, R;Yoshioka, A;Nakamura, K;Passariello, M;De Lorenzo, C; A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies Cancers 2023-11-09 [PMID: 38001604] (Bioassay, Human) Bioassay Human
Carter, R;Alanazi, F;Sharp, A;Roman, J;Luchini, A;Liotta, L;Paige, M;Brown, AM;Haymond, A; Identification of the Functional PD-L1 Interface Region Responsible for PD-1 Binding and Initiation of PD-1 Signaling The Journal of biological chemistry 2023-10-17 [PMID: 37858677] (Bioassay, Human) Bioassay Human
Rattanapisit, K;Bulaon, CJI;Strasser, R;Sun, H;Phoolcharoen, W; In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody Scientific reports 2023-08-29 [PMID: 37644118] (ELISA Standard, Human) ELISA Standard Human
Lorenzini, T;Cadilha, BL;Obeck, H;Benmebarek, MR;Märkl, F;Michaelides, S;Strzalkowski, T;Briukhovetska, D;Müller, PJ;Nandi, S;Winter, P;Majed, L;Grünmeier, R;Seifert, M;Rausch, S;Feuchtinger, T;Endres, S;Kobold, S; Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy British journal of cancer 2023-07-04 [PMID: 37400680] (Flow Cytometry, Human) Flow Cytometry Human
Coulet, M;Lachkar, S;Leduc, M;Trombe, M;Gouveia, Z;Perez, F;Kepp, O;Kroemer, G;Basmaciogullari, S; Identification of Small Molecules Affecting the Secretion of Therapeutic Antibodies with the Retention Using Selective Hook (RUSH) System Cells 2023-06-16 [PMID: 37371112] (ELISA Capture, Human) ELISA Capture Human
O Munoz, R Banga, R Schelling, FA Procopio, A Mastrangel, P Nortier, K Ohmiti, J Daraspe, M Cavassini, C Fenwick, L Perez, M Perreau Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells PloS Pathogens, 2022-07-05;18(7):e1010673. 2022-07-05 [PMID: 35788752] (Bioassay, Human) Bioassay Human
Show All 32 Publications.

Reviews for PD-L1 (156-B7) (0)

There are no reviews for PD-L1 (156-B7). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for PD-L1 (156-B7) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional PD-L1 Products

Blogs on PD-L1.

Unlocking the Potential of Biosimilars in Immuno-Oncology
By Jennifer Jones, M.S.Biosimilar Antibodies: Imitation Meets InnovationIn the ever-evolving medical landscape, a new class of pharmaceuticals is emerging as a game-changer, poised to transform the way we approach...  Read full blog post.

Synthetic Biotic Medicine as Immunotherapy Against Cancer: Evidence From Arginine-Producing Engineered Bacteria
By Jamshed Arslan, Pharm D, PhDWhat do nuts, dairy and red meat have in common? In addition to the fact that they are all edible, one of the answers is L-arginine. This amino acid improves T cell’s respons...  Read full blog post.

Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human PD-L1/B7-H1 Fc Chimera Protein, CF and receive a gift card or discount.

Bioinformatics

Gene Symbol CD274
Uniprot